WJ-39, an Aldose Reductase Inhibitor, Ameliorates Renal Lesions in Diabetic Nephropathy by Activating Nrf2 Signaling
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
WJ-39, an Aldose Reductase Inhibitor, Ameliorates Renal Lesions in Diabetic Nephropathy by Activating Nrf2 Signaling
Authors
Keywords
-
Journal
Oxidative Medicine and Cellular Longevity
Volume 2020, Issue -, Pages 1-21
Publisher
Hindawi Limited
Online
2020-05-31
DOI
10.1155/2020/7950457
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Amelioration of diabetic nephropathy using pomegranate peel extract-stabilized gold nanoparticles: assessment of NF-κB and Nrf2 signaling system
- (2019) Krishnendu Manna et al. International Journal of Nanomedicine
- Transforming growth factor β (TGFβ) and related molecules in chronic kidney disease (CKD)
- (2019) Pacific Huynh et al. CLINICAL SCIENCE
- Predictable chronic mild stress promotes recovery from LPS-induced depression
- (2019) Ruili Dang et al. Molecular Brain
- The aldose reductase inhibitor epalrestat exerts nephritic protection on diabetic nephropathy in db/db mice through metabolic modulation
- (2018) Jun He et al. ACTA PHARMACOLOGICA SINICA
- Update on Diabetic Nephropathy: Core Curriculum 2018
- (2018) Kausik Umanath et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Epidemiology of diabetes and diabetic complications in China
- (2018) Ronald C. W. Ma DIABETOLOGIA
- Diabetic nephropathy: Is there a role for oxidative stress?
- (2018) Manpreet K. Sagoo et al. FREE RADICAL BIOLOGY AND MEDICINE
- Chlorogenic acid prevents diabetic nephropathy by inhibiting oxidative stress and inflammation through modulation of the Nrf2/HO-1 and NF-ĸB pathways
- (2018) Liping Bao et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Sitagliptin ameliorates diabetic nephropathy by blocking TGF-β1/Smad signaling pathway
- (2018) Dongdong Wang et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease
- (2018) Hans-Joachim Anders et al. Nature Reviews Nephrology
- Astaxanthin Promotes Nrf2/ARE Signaling to Alleviate Renal Fibronectin and Collagen IV Accumulation in Diabetic Rats
- (2018) Xiaoyu Zhu et al. Journal of Diabetes Research
- Effects of antidiabetic drugs on NLRP3 inflammasome activity, with a focus on diabetic kidneys
- (2018) Habib Yaribeygi et al. DRUG DISCOVERY TODAY
- Calcitriol inhibits ROS-NLRP3-IL-1β signaling axis via activation of Nrf2-antioxidant signaling in hyperosmotic stress stimulated human corneal epithelial cells
- (2018) Yiqin Dai et al. Redox Biology
- Aldose Reductase Mediates NLRP3 Inflammasome–Initiated Innate Immune Response in Hyperglycemia-Induced Thp1 Monocytes and Male Mice
- (2017) Pabitra B Pal et al. ENDOCRINOLOGY
- Dencichine ameliorates kidney injury in induced type II diabetic nephropathy via the TGF-β/Smad signalling pathway
- (2017) Li Jie et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Structured DAG oil ameliorates renal injury in streptozotocin-induced diabetic rats through inhibition of NF-κB and activation of Nrf2 pathway
- (2017) Kankana Das et al. FOOD AND CHEMICAL TOXICOLOGY
- Aldose reductase inhibitors attenuate β-amyloid-induced TNF-α production in microlgia via ROS-PKC-mediated NF-κB and MAPK pathways
- (2017) Xiao-Min Song et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Kidney Fibrosis
- (2017) Thomas Vanhove et al. TRANSPLANTATION
- Role of Nuclear Factor Erythroid 2-Related Factor 2 in Diabetic Nephropathy
- (2017) Wenpeng Cui et al. Journal of Diabetes Research
- CKIP-1 ameliorates high glucose-induced expression of fibronectin and intercellular cell adhesion molecule-1 by activating the Nrf2/ARE pathway in glomerular mesangial cells
- (2016) Wenyan Gong et al. BIOCHEMICAL PHARMACOLOGY
- Podocytes: the Weakest Link in Diabetic Kidney Disease?
- (2016) Jamie S. Lin et al. Current Diabetes Reports
- The origin of renal fibroblasts/myofibroblasts and the signals that trigger fibrosis
- (2016) Yu Bo Yang Sun et al. DIFFERENTIATION
- Mechanistic insight of diabetic nephropathy and its pharmacotherapeutic targets: An update
- (2016) Niloy Bhattacharjee et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Anti-Inflammatory Therapy Modulates Nrf2-Keap1 in Kidney from Rats with Diabetes
- (2016) Abraham Said Arellano-Buendía et al. Oxidative Medicine and Cellular Longevity
- Roles of the NLRP3 inflammasome in the pathogenesis of diabetic nephropathy
- (2016) Yuan-ye Qiu et al. PHARMACOLOGICAL RESEARCH
- Aldose Reductase as a Drug Target for Treatment of Diabetic Nephropathy: Promises and Challenges
- (2016) Heba Gamal et al. PROTEIN AND PEPTIDE LETTERS
- High Glucose and Lipopolysaccharide Prime NLRP3 Inflammasome via ROS/TXNIP Pathway in Mesangial Cells
- (2016) Hong Feng et al. Journal of Diabetes Research
- Stabilization of endogenous Nrf2 by minocycline protects against Nlrp3-inflammasome induced diabetic nephropathy
- (2016) Khurrum Shahzad et al. Scientific Reports
- Therapeutic strategies of diabetic nephropathy: recent progress and future perspectives
- (2015) Meng Lv et al. DRUG DISCOVERY TODAY
- Updates on Aldose Reductase Inhibitors for Management of Diabetic Complications and Non-diabetic Diseases
- (2015) Ajmer Singh Grewal et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Renal Kallikrein Activation and Renoprotection after Dual Blockade of Renin-Angiotensin System in Diet-Induced Diabetic Nephropathy
- (2015) Xia Zou et al. Journal of Diabetes Research
- Epalrestat increases glutathione, thioredoxin, and heme oxygenase-1 by stimulating Nrf2 pathway in endothelial cells
- (2015) Kaori Yama et al. Redox Biology
- Identification of Novel Aldose Reductase Inhibitors from Spices: A Molecular Docking and Simulation Study
- (2015) Priya Antony et al. PLoS One
- Thioredoxin-interacting protein mediates NALP3 inflammasome activation in podocytes during diabetic nephropathy
- (2014) Pan Gao et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Polysaccharides from Liriopes Radix ameliorate streptozotocin-induced type I diabetic nephropathy via regulating NF-κB and p38 MAPK signaling pathways
- (2014) Hung-Jen Lu et al. BMC Complementary and Alternative Medicine
- Aldose reductase regulates miR-200a-3p/141-3p to coordinate Keap1–Nrf2, Tgfβ1/2, and Zeb1/2 signaling in renal mesangial cells and the renal cortex of diabetic mice
- (2013) Jie Wei et al. FREE RADICAL BIOLOGY AND MEDICINE
- The Nrf2 pathway in the progression of renal disease
- (2013) C. Zoja et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Transforming growth factor- and the progression of renal disease
- (2013) I. Loeffler et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Inflammation and the pathogenesis of diabetic nephropathy
- (2012) Jun Wada et al. CLINICAL SCIENCE
- Anti-Fibrosis Therapy and Diabetic Nephropathy
- (2012) Anil Karihaloo Current Diabetes Reports
- Development and validation of a rapid high-performance liquid chromatography-tandem mass spectrometry method for the determination of WJ-38, a novel aldose reductase inhibitor, in rat plasma and its application to a pharmacokinetic study
- (2012) Jing Lu et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Inflammation in Diabetic Nephropathy
- (2012) Andy K. H. Lim et al. MEDIATORS OF INFLAMMATION
- Aldose reductase inhibition suppresses oxidative stress-induced inflammatory disorders
- (2011) Satish K. Srivastava et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Cutting Edge: Reactive Oxygen Species Inhibitors Block Priming, but Not Activation, of the NLRP3 Inflammasome
- (2011) F. Bauernfeind et al. JOURNAL OF IMMUNOLOGY
- Indoxyl Sulfate Upregulates Expression of ICAM-1 and MCP-1 by Oxidative Stress-Induced NF-ĸB Activation
- (2010) Zohra Tumur et al. AMERICAN JOURNAL OF NEPHROLOGY
- Cutting Edge: NF- B Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression
- (2009) F. G. Bauernfeind et al. JOURNAL OF IMMUNOLOGY
- Induction of Heme Oxygenase-1 is a Beneficial Response in a Murine Model of Venous Thrombosis
- (2008) Michal J. Tracz et al. AMERICAN JOURNAL OF PATHOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started